Lucas Opazo-Ríos
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Co-authors
- Jesús Egido (17 shared papers)Juan Antonio Moreno (12 shared papers)Carmen Gómez‐Guerrero (9 shared papers)Sebastián Mas (8 shared papers)Sergio Mezzano (6 shared papers)Gema Marín‐Royo (4 shared papers)Ana B. Sanz (2 shared papers)Sandra Rayego‐Mateos (6 shared papers)
- Journals
- International Journal of Molecular Sciences (7 papers)Antioxidants (3 papers)Journal of Clinical Medicine (2 papers)The Journal of Pathology (2 papers)BMJ Open Diabetes Research & Care (1 paper)
- Partner nations
- SpainChileUnited States
In The Last Decade
Lucas Opazo-Ríos
19 papers receiving 1.0k citations
Lucas Opazo-Ríos's Hit Papers
Peers
Comparison fields: 5 of 92
- Nephrology 291
- Clinical Biochemistry 122
- Endocrinology, Diabetes and Metabolism 200
- Immunology 169
- Biochemistry 44
Countries citing papers authored by Lucas Opazo-Ríos
This map shows the geographic impact of Lucas Opazo-Ríos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Opazo-Ríos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Opazo-Ríos more than expected).
Fields of papers citing papers by Lucas Opazo-Ríos
This network shows the impact of papers produced by Lucas Opazo-Ríos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Opazo-Ríos. The network helps show where Lucas Opazo-Ríos may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucas Opazo-Ríos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities Hit paper breakdown → | 2020 | 251 |
| 2 | Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy Hit paper breakdown → | 2020 | 232 |
| 3 | 2018 | 142 | |
| 4 | 2020 | 83 | |
| 5 | 2020 | 79 | |
| 6 | 2021 | 59 | |
| 7 | 2020 | 34 | |
| 8 | 2016 | 27 | |
| 9 | 2024 | 22 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 15 | |
| 12 | 2022 | 12 | |
| 13 | 2022 | 9 | |
| 14 | 2022 | 9 | |
| 15 | 2021 | 6 | |
| 16 | 2024 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2021 | 1 | |
| 20 | 2025 | 0 |
About Lucas Opazo-Ríos
Lucas Opazo-Ríos is a scholar working on Immunology, Molecular Biology, Nephrology, Epidemiology and Clinical Biochemistry, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Chronic Kidney Disease and Diabetes (3 papers), MicroRNA in disease regulation (2 papers), Diet, Metabolism, and Disease (2 papers), Natural Antidiabetic Agents Studies (2 papers) and Acute Kidney Injury Research (2 papers). The work is most often cited by research in Nephrology (291 citations), Clinical Biochemistry (122 citations), Endocrinology, Diabetes and Metabolism (200 citations), Immunology (169 citations) and Biochemistry (44 citations). Lucas Opazo-Ríos has collaborated with scholars based in Spain, Chile and United States. Frequent co-authors include Jesús Egido, Juan Antonio Moreno, Carmen Gómez‐Guerrero, Sebastián Mas, Sergio Mezzano, Gema Marín‐Royo, Ana B. Sanz, Sandra Rayego‐Mateos, Carmen Herencia and Melania Guerrero‐Hue. Their work appears in journals such as International Journal of Molecular Sciences, Antioxidants, Journal of Clinical Medicine, The Journal of Pathology and BMJ Open Diabetes Research & Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.